Wilson Sonsini Goodrich & Rosati advised Vertos Medical Inc. on the transaction. Stryker (NYSE: SYK), a global leader in medical technologies, announced a definitive agreement to...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Sanofi in the transaction, and Wilson Sonsini Goodrich & Rosati represented Ventyx Biosciences, Inc. Sanofi announced a $27 million strategic investment in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised JP Morgan Life Sciences Private Capital on the transaction. Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Cleveland Diagnostics on the transaction. Cleveland Diagnostics, a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction. ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is advising DTx Pharma on the transaction. A preclinical-stage biotechnology company, DTx Pharma announced that it has been acquired by Novartis. In addition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Voluware on the deal. Voluware, an award-winning provider of solutions to speed and simplify prior authorizations, announced a capital investment...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised LinusBio on the deal. Linus Biotechnology received $16 million in venture capital financing for its R&D efforts to establish a method for predicting...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ventyx Biosciences on the deal while Goodwin Procter represented Redmile Group. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Trutino Biosciences on the deal. Boehringer Ingelheim, a leading research-driven biopharmaceutical company, announced the signing of an option to acquire...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Nalu Medical on the deal. Nalu Medical, Inc., a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal. Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living...
You must be a Standard 1 Year member to access this content.
